|
Volumn 356, Issue 9225, 2000, Pages
|
PEP trial. Pulmonary Embolism Prevention.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
PLACEBO;
AGED;
CEREBROVASCULAR ACCIDENT;
HEART INFARCTION;
HIP ARTHROPLASTY;
HIP FRACTURE;
HUMAN;
LETTER;
LUNG EMBOLISM;
MALE;
PROPORTIONAL HAZARDS MODEL;
RISK FACTOR;
VEIN THROMBOSIS;
AGED;
ARTHROPLASTY, REPLACEMENT, HIP;
ASPIRIN;
CEREBROVASCULAR ACCIDENT;
HIP FRACTURES;
HUMANS;
MALE;
MYOCARDIAL INFARCTION;
PLACEBOS;
PLATELET AGGREGATION INHIBITORS;
PROPORTIONAL HAZARDS MODELS;
PULMONARY EMBOLISM;
RISK FACTORS;
VENOUS THROMBOSIS;
|
EID: 0034660976
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(05)74499-8 Document Type: Letter |
Times cited : (7)
|
References (0)
|